Biosimilar for tremfya?

Short answer: as of now, there are no FDA- or EMA-approved biosimilars of Tremfya (guselkumab).

- Several companies are developing guselkumab biosimilars, but none have completed regulatory approval yet (status can vary by country).
- If you want the latest status for your location, tell me your country and I can check the current approvals.
- If cost or access is the goal, talk with your prescribed physician about options (patient assistance programs for Tremfya, or switching to an approved alternative therapy if a guselkumab biosimilar becomes available).
- A biosimilar is a highly similar version of a biologic; there are no true “generics” for complex proteins like guselkumab yet.

Would you like me to look up the current status for your country? If so, which country are you in?